argenx SE ( ARGNF) - Key Metrics
ARGNF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $39.56 | $14.38 | $6.30 | $6.29 |
| 2025Q2 | $13.36 | $3.46 | $5.10 | $5.03 |
| 2025Q1 | ? | ? | ? | ? |
| 2024Q4 | $18.97 | $11.78 | $0.57 | $0.56 |
| 2024Q2 | $14.17 | -$0.51 | -$1.96 | -$1.97 |
ARGNF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 14.63 |
| 2025Q2 | ? | 40.03 |
| 2025Q1 | ? | ? |
| 2024Q4 | ? | 13.19 |
| 2024Q2 | ? | -211.92 |
ARGNF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 0.72% | ? |
| 2025Q2 | 1.39% | ? |
| 2025Q1 | ? | ? |
| 2024Q4 | 0.10% | ? |
| 2024Q2 | -0.45% | ? |
ARGNF
Price: $900
52 week price:
Earnings Per Share: 22.49 USD
P/E Ratio: 35.71
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 51.7 billion